A detailed history of State Board Of Administration Of Florida Retirement System transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, State Board Of Administration Of Florida Retirement System holds 37,980 shares of HALO stock, worth $2.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37,980
Previous 37,980 -0.0%
Holding current value
$2.01 Million
Previous $1.99 Million 9.26%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$37.81 - $52.4 $134,981 - $187,068
-3,570 Reduced 8.59%
37,980 $1.99 Million
Q1 2024

May 08, 2024

BUY
$33.68 - $41.95 $117,880 - $146,825
3,500 Added 9.2%
41,550 $1.69 Million
Q3 2023

Nov 08, 2023

BUY
$36.46 - $44.03 $5,104 - $6,164
140 Added 0.37%
38,050 $1.45 Million
Q2 2023

Aug 11, 2023

SELL
$30.28 - $38.74 $110,219 - $141,013
-3,640 Reduced 8.76%
37,910 $1.37 Million
Q4 2022

Feb 07, 2023

SELL
$40.06 - $59.44 $350,925 - $520,694
-8,760 Reduced 17.41%
41,550 $2.36 Million
Q3 2022

Nov 08, 2022

SELL
$38.53 - $51.78 $30,438 - $40,906
-790 Reduced 1.55%
50,310 $1.99 Million
Q2 2022

Aug 05, 2022

SELL
$37.35 - $48.3 $91,881 - $118,818
-2,460 Reduced 4.59%
51,100 $2.25 Million
Q4 2021

Feb 08, 2022

SELL
$31.82 - $40.75 $4,263 - $5,460
-134 Reduced 0.25%
53,560 $2.15 Million
Q1 2021

May 10, 2021

SELL
$39.51 - $51.45 $875,541 - $1.14 Million
-22,160 Reduced 29.21%
53,694 $2.24 Million
Q4 2020

Feb 08, 2021

SELL
$25.81 - $43.62 $409,088 - $691,377
-15,850 Reduced 17.28%
75,854 $3.24 Million
Q2 2018

Aug 06, 2018

BUY
$16.87 - $20.3 $2,530 - $3,045
150 Added 0.16%
91,704 $1.55 Million
Q3 2017

Oct 31, 2017

BUY
$11.76 - $17.4 $1.08 Million - $1.59 Million
91,554
91,554 $1.59 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $7.35B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.